COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology.


Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
11 2021
Historique:
revised: 08 09 2021
received: 19 06 2021
accepted: 28 09 2021
pubmed: 7 10 2021
medline: 15 12 2021
entrez: 6 10 2021
Statut: ppublish

Résumé

Patients with heart failure (HF) who contract SARS-CoV-2 infection are at a higher risk of cardiovascular and non-cardiovascular morbidity and mortality. Regardless of therapeutic attempts in COVID-19, vaccination remains the most promising global approach at present for controlling this disease. There are several concerns and misconceptions regarding the clinical indications, optimal mode of delivery, safety and efficacy of COVID-19 vaccines for patients with HF. This document provides guidance to all healthcare professionals regarding the implementation of a COVID-19 vaccination scheme in patients with HF. COVID-19 vaccination is indicated in all patients with HF, including those who are immunocompromised (e.g. after heart transplantation receiving immunosuppressive therapy) and with frailty syndrome. It is preferable to vaccinate against COVID-19 patients with HF in an optimal clinical state, which would include clinical stability, adequate hydration and nutrition, optimized treatment of HF and other comorbidities (including iron deficiency), but corrective measures should not be allowed to delay vaccination. Patients with HF who have been vaccinated against COVID-19 need to continue precautionary measures, including the use of facemasks, hand hygiene and social distancing. Knowledge on strategies preventing SARS-CoV-2 infection (including the COVID-19 vaccination) should be included in the comprehensive educational programmes delivered to patients with HF.

Identifiants

pubmed: 34612556
doi: 10.1002/ejhf.2356
pmc: PMC8652673
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1806-1818

Informations de copyright

© 2021 European Society of Cardiology.

Références

J Infect Dis. 2021 Mar 29;223(6):945-956
pubmed: 33325510
JACC Basic Transl Sci. 2021 Mar;6(3):202-218
pubmed: 33649738
Clin Infect Dis. 2021 Jul 1;73(1):43-49
pubmed: 32507899
JAMA Cardiol. 2021 Oct 1;6(10):1196-1201
pubmed: 34185046
Front Immunol. 2020 Jul 13;11:1313
pubmed: 32754150
J Clin Med. 2021 Jan 17;10(2):
pubmed: 33477268
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Eur J Heart Fail. 2016 Jul;18(7):744-58
pubmed: 27358242
J Am Coll Cardiol. 2018 Feb 20;71(7):782-793
pubmed: 29447741
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Eur Heart J Qual Care Clin Outcomes. 2021 Jul 21;7(4):378-387
pubmed: 34043762
N Engl J Med. 2021 Aug 26;385(9):790-802
pubmed: 34351721
ESC Heart Fail. 2021 Apr;8(2):1691-1695
pubmed: 33410281
Lancet Infect Dis. 2021 Feb;21(2):e26-e35
pubmed: 33125914
Br J Haematol. 2003 Feb;120(4):574-96
pubmed: 12588344
Nutrients. 2020 Jan 16;12(1):
pubmed: 31963293
JACC Heart Fail. 2020 Jun;8(6):512-514
pubmed: 32360242
N Engl J Med. 2021 Aug 12;385(7):661-662
pubmed: 34161700
Eur Heart J. 2013 Mar;34(11):827-34
pubmed: 23178646
ESC Heart Fail. 2020 Sep 30;:
pubmed: 32997438
Eur J Heart Fail. 2020 Dec;22(12):2219-2224
pubmed: 32809274
Respir Res. 2020 Apr 15;21(1):83
pubmed: 32293449
J Heart Lung Transplant. 2021 Mar;40(3):169-171
pubmed: 33487534
Rev Med Virol. 2021 May;31(3):e2180
pubmed: 33022834
Eur J Heart Fail. 2021 Mar;23(3):468-475
pubmed: 33421274
Am Heart J. 2013 Apr;165(4):575-582.e3
pubmed: 23537975
Am J Med. 2021 Apr;134(4):482-489
pubmed: 33010226
Med (N Y). 2021 Feb 12;2(2):164-179.e12
pubmed: 33665641
JAMA Cardiol. 2020 Oct 1;5(10):1165-1169
pubmed: 32402056
S Afr Med J. 1978 Mar 18;53(11):405-7
pubmed: 675375
Eur J Heart Fail. 2020 Dec;22(12):2205-2215
pubmed: 32833283
Lancet Respir Med. 2021 Mar;9(3):275-284
pubmed: 33422263
JACC Heart Fail. 2021 Jan;9(1):52-61
pubmed: 33309578
Eur J Heart Fail. 2019 Nov;21(11):1299-1305
pubmed: 31646718
Eur Heart J. 2020 Dec 1;41(45):4298-4300
pubmed: 33063119
Indian Heart J. 2021 Jan-Feb;73(1):91-98
pubmed: 33714416
Lancet. 2021 May 8;397(10286):1725-1735
pubmed: 33901423
Arch Immunol Ther Exp (Warsz). 2010 Dec;58(6):407-15
pubmed: 20878249
ESC Heart Fail. 2020 Dec;7(6):3408-3413
pubmed: 33284510
Lancet. 2021 May 1;397(10285):1646-1657
pubmed: 33901420
J Gerontol A Biol Sci Med Sci. 1999 Feb;54(2):M59-64
pubmed: 10051856
Nat Rev Immunol. 2020 Oct;20(10):615-632
pubmed: 32887954
Mol Aspects Med. 2020 Oct;75:100864
pubmed: 32461004
Eur J Cardiovasc Nurs. 2020 Aug;19(6):486-494
pubmed: 32380858
Blood Rev. 2021 Jan;45:100707
pubmed: 32425294
Am J Transplant. 2021 Oct;21(10):3496-3499
pubmed: 33890410
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Int J Infect Dis. 2016 Aug;49:129-33
pubmed: 27352628
Eur J Heart Fail. 2021 Sep;23(9):1555-1559
pubmed: 33963635
Curr Opin Support Palliat Care. 2021 Jun 1;15(2):147-153
pubmed: 33843761
Nat Commun. 2019 Jul 3;10(1):2935
pubmed: 31270335
Clin Exp Immunol. 2020 Nov;202(2):162-192
pubmed: 32935331
Int Immunopharmacol. 2021 Nov;100:108121
pubmed: 34492533
Circulation. 2021 Aug 10;144(6):471-484
pubmed: 34281357
Nature. 2020 Aug;584(7821):443-449
pubmed: 32668443
Ann Intern Med. 2021 Sep;174(9):1336-1338
pubmed: 34029487
JAMA. 2021 Jan 19;325(3):254-264
pubmed: 33464336
Heart. 2020 Mar;106(5):350-357
pubmed: 31444266
Clin Res Cardiol. 2020 Dec;109(12):1531-1539
pubmed: 32783099
Eur J Heart Fail. 2020 Oct;22(10):1755-1758
pubmed: 32506703
Eur Heart J. 2020 May 14;41(19):1821-1829
pubmed: 32383763
Eur J Heart Fail. 2020 Jun;22(6):978-984
pubmed: 32478951
Curr Clin Microbiol Rep. 2021 Feb 15;:1-15
pubmed: 33614398
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1423-1437
pubmed: 33388478
J Am Coll Cardiol. 2020 Oct 13;76(15):1777-1794
pubmed: 33032740
Am J Cardiol. 2020 Aug 1;128:134-139
pubmed: 32650907
Eur J Heart Fail. 2020 Dec;22(12):2190-2201
pubmed: 33135851
Lancet. 2021 Dec 19;396(10267):1979-1993
pubmed: 33220855
J Am Coll Cardiol. 2014 Dec 2;64(21):2281-93
pubmed: 25456761
Eur J Heart Fail. 2020 Jun;22(6):1045-1046
pubmed: 32469132
Circulation. 2020 May 19;141(20):1648-1655
pubmed: 32200663
JAMA Cardiol. 2020 Jul 1;5(7):831-840
pubmed: 32219363
J Infect Public Health. 2020 Nov;13(11):1619-1629
pubmed: 32718895
Am J Med Sci. 2021 Jan;361(1):14-22
pubmed: 33187633
JAMA. 2021 Jun 22;325(24):2500-2502
pubmed: 33956050
J Am Coll Cardiol. 2021 Apr 20;77(15):1938-1948
pubmed: 33587998
Eur J Heart Fail. 2021 Mar;23(3):476-485
pubmed: 33222412
Hum Antibodies. 2020;28(4):287-297
pubmed: 32986664
N Engl J Med. 2021 May 6;384(18):1774-1775
pubmed: 33755376
BMJ. 2021 May 5;373:n1159
pubmed: 33952506
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620936776
pubmed: 32687449
Clin Med (Lond). 2020 Sep;20(5):e148-e153
pubmed: 32709637
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
Cochrane Database Syst Rev. 2021 Mar 11;3:CD013879
pubmed: 33704775
JAMA. 2021 Jun 1;325(21):2204-2206
pubmed: 33950155

Auteurs

Giuseppe Rosano (G)

IRCCS San Raffaele, Rome, Italy.

Ewa A Jankowska (EA)

Institute of Heart Diseases, Wrocław Medical University, Wrocław, Poland.

Robin Ray (R)

Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Institute, St George's, University of London, St George's Hospital, London, UK.

Marco Metra (M)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Magdy Abdelhamid (M)

Faculty of Medicine, Kasr Al Ainy, Department of Cardiology, Cairo University, Giza, Egypt.

Stamatis Adamopoulos (S)

Heart Failure - Transplant - Mechanical Circulatory Support Unit, Onassis Cardiac Surgery Center, Athens, Greece.

Stefan D Anker (SD)

Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin, Berlin, Germany.

Antoni Bayes-Genis (A)

Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona & CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.

Yury Belenkov (Y)

I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Tuvia B Gal (TB)

Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel, & Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Michael Böhm (M)

Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Saarland University, Kardiologie, Angiologie und Internistische Intensivmedizin, Homburg/Saar, Germany.

Ovidiu Chioncel (O)

Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', University of Medicine Carol Davila, Bucharest, Romania.

Alain Cohen-Solal (A)

UMR-S 942 Research Unit, Paris University, Lariboisiere Hospital, Cardiology Department, AP-HP, Paris, France.

Dimitrios Farmakis (D)

University of Cyprus Medical School, Nicosia, Cyprus.

Gerasimos Filippatos (G)

National and Kapodistrian University of Athens, School of Medicine, University Hospital Attikon, Athens, Greece.

Arantxa González (A)

Program of Cardiovascular Diseases, CIMA Universidad de Navarra, IdiSNA and CIBERCV, Pamplona, Spain.

Finn Gustafsson (F)

Department of Cardiology, University of Copenhagen, Copenhagen, Denmark.

Loreena Hill (L)

School of Nursing & Midwifery, Queen's University, Belfast, Northern Ireland, UK.

Tiny Jaarsma (T)

Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Fadi Jouhra (F)

Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Institute, St George's, University of London, St George's Hospital, London, UK.

Mitja Lainscak (M)

Division of Cardiology, General Hospital Murska Sobota, Murska Sobota, Slovenia, & Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Ekaterini Lambrinou (E)

Department of Nursing, School of Health Sciences, Cyprus University of Technology, Limassol, Cyprus.

Yury Lopatin (Y)

Volgograd State Medical University, Regional Cardiology Centre, Volgograd, Russian Federation.

Lars H Lund (LH)

Department of Medicine, Karolinska Institutet, and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.

Davor Milicic (D)

University of Zagreb School of Medicine, Zagreb, Croatia.

Brenda Moura (B)

Armed Forces Hospital, Porto, & Faculty of Medicine, University of Porto, Porto, Portugal.

Wilfried Mullens (W)

Cardiovascular Physiology, Hasselt University, Belgium, & Heart Failure and Cardiac Rehabilitation Specialist, Ziekenhuis Oost-Limburg, Genk, Belgium.

Massimo F Piepoli (MF)

Cardiac Unit, Guglielmo da Saliceto Hospital, University of Parma, Piacenza, Italy.

Piotr Ponikowski (P)

Institute of Heart Diseases, Wrocław Medical University, Wrocław, Poland.

Amina Rakisheva (A)

Department of Cardiology, Scientific Institution of Cardiology and Internal Diseases, Almaty, Kazakhstan.

Arsen Ristic (A)

Department of Cardiology, University Clinical Center of Serbia, Belgrade University School of Medicine, Belgrade, Serbia.

Gianluigi Savarese (G)

Department of Medicine, Karolinska Institutet, and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.

Petar Seferovic (P)

Department Faculty of Medicine, University of Belgrade, Belgrade & Serbian Academy of Sciences and Arts, Belgrade, Serbia.

Michele Senni (M)

Cardiovascular Department, Cardiology 1 Unit, Papa Giovanni XXIII Hospital Bergamo, University of Milano - Bicocca, Bergamo, Italy.

Thomas Thum (T)

Institute of Molecular and Therapeutic Strategies, Hannover & Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany.

Carlo G Tocchetti (CG)

Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research (CISI), Interdepartmental Center of Clinical and Translational Sciences (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy.

Sophie Van Linthout (S)

Berlin Institute of Health at Charité - Universitätmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, German Center for Cardiovascular Research (DZHK), Partner site Berlin, Berlin, Germany.

Maurizio Volterrani (M)

Cardiovascular Pulmonary Science Department, IRCCS San Raffaele, Roma, Italy.

Andrew J S Coats (AJS)

University of Warwick, Coventry, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH